For more information, visit www.aelisfarma.com and follow us on LinkedIn and Twitter ... Some information contained in this press release is forward-looking statements, not historical data.
... information ... This announcement contains information that qualifies, or may have qualified, as inside information within the meaning of Article 7(1) of Regulation (EU) No 596/2014 on market abuse.
) Insider information ...Company. Sopharma AD (SFA) ... Disclaimer. Sopharma AD published this content on March 20, 2026, and is solely responsible for the information contained herein.
). Auction date. N. of shares purchased. by the Specialist. Value purchased by the Specialist. (€). N. of shares sold by. the Specialist ... (€). N ... exchanged ... published this content on March 20, 2026, and is solely responsible for the information contained herein.
The Issuer accepts responsibility for the information contained in this notice ... For information on DocuSign's terms of use, click here. For information on DocuSign's privacy policy, click here.
Other information for investors ... These summarized annual consolidated financial statements are published pursuant to NHI's obligation to provide information to qualified investors under U.S.
This press release constitutes a public disclosure of inside information under Regulation (EU) 596/2014 (16 April 2014) and Implementing Regulation (EU) No 2016/1055 (10 June 2016).
... inside the mitochondria using an AAV vector (Adeno-Associated Virus) ... Gensight Biologics SA published this content on March 20, 2026, and is solely responsible for the information contained herein.